Bhargava P - Search Results

1

Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor.

Marshall JL, Kindler H, Deeken J, Bhargava P, Vogelzang NJ, Rizvi N, Luhtala T, Boylan S, Dordal M, Robertson P, Hawkins MJ, Ratain MJ. Marshall JL, et al. Among authors: bhargava p. Invest New Drugs. 2005 Jan;23(1):31-7. doi: 10.1023/B:DRUG.0000047103.64335.b0. Invest New Drugs. 2005. PMID: 15528978 Clinical Trial.

2

Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer.

Bhargava P, Marshall JL, Fried K, Williams M, Lefebvre P, Dahut W, Hanfelt J, Gehan E, Figuera M, Hawkins MJ, Rizvi NA. Bhargava P, et al. Cancer Chemother Pharmacol. 2001 Aug;48(2):95-103. doi: 10.1007/s002800100317. Cancer Chemother Pharmacol. 2001. PMID: 11561784 Clinical Trial.

3

A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.

Bhargava P, Marshall JL, Dahut W, Rizvi N, Trocky N, Williams JI, Hait H, Song S, Holroyd KJ, Hawkins MJ. Bhargava P, et al. Clin Cancer Res. 2001 Dec;7(12):3912-9. Clin Cancer Res. 2001. PMID: 11751482 Clinical Trial.

4

Matrix metalloproteinase inhibitors in cancer: an update.

Marshall JL, Baidas S, Bhargava P, Rizvi N. Marshall JL, et al. Among authors: bhargava p. IDrugs. 2000 May;3(5):518-24. IDrugs. 2000. PMID: 16100684 No abstract available.

5

Phase I study of prolonged infusion Bryostatin-1 in patients with advanced malignancies.

Marshall JL, Bangalore N, El-Ashry D, Fuxman Y, Johnson M, Norris B, Oberst M, Ness E, Wojtowicz-Praga S, Bhargava P, Rizvi N, Baidas S, Hawkins MJ. Marshall JL, et al. Among authors: bhargava p. Cancer Biol Ther. 2002 Jul-Aug;1(4):409-16. doi: 10.4161/cbt.1.4.17. Cancer Biol Ther. 2002. PMID: 12432257 Clinical Trial.

6

A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer.

Bhargava P, Marshall JL, Rizvi N, Dahut W, Yoe J, Figuera M, Phipps K, Ong VS, Kato A, Hawkins MJ. Bhargava P, et al. Clin Cancer Res. 1999 Aug;5(8):1989-95. Clin Cancer Res. 1999. PMID: 10473076 Clinical Trial.

7

Docetaxel and gemcitabine combinations in non-small cell lung cancer.

Rizvi NA, Spiridonidis CH, Davis TH, Bhargava P, Marshall JL, Dahut W, Figuera M, Hawkins MJ. Rizvi NA, et al. Among authors: bhargava p. Semin Oncol. 1999 Oct;26(5 Suppl 16):27-31; discussion 41-2. Semin Oncol. 1999. PMID: 10585006 Review.

8

Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: case report and review of the literature.

Bangalore N, Bhargava P, Hawkins MJ, Bhargava P. Bangalore N, et al. Among authors: bhargava p. Ann Oncol. 2001 Feb;12(2):271-4. doi: 10.1023/a:1008352024762. Ann Oncol. 2001. PMID: 11300337 Free article. Review.

9

A discordance of the cytochrome P450 2C19 genotype and phenotype in patients with advanced cancer.

Williams ML, Bhargava P, Cherrouk I, Marshall JL, Flockhart DA, Wainer IW. Williams ML, et al. Among authors: bhargava p. Br J Clin Pharmacol. 2000 May;49(5):485-8. doi: 10.1046/j.1365-2125.2000.00189.x. Br J Clin Pharmacol. 2000. PMID: 10792207 Free PMC article.

10

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O'Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL, Goldberg RM. Kindler HL, et al. Among authors: bhargava p. J Clin Oncol. 2010 Aug 1;28(22):3617-22. doi: 10.1200/JCO.2010.28.1386. Epub 2010 Jul 6. J Clin Oncol. 2010. PMID: 20606091 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

859 results

Search Page